The effect of fenoterol on fetal metabolism: cord blood studies.
Albumin, total protein, total bilirubin, glucose, cholesterol, triglycerides, blood urea nitrogen, alkaline phosphatase and glutamic oxaloacetic transaminase levels were determined in the serum of cord blood of neonates born to mothers previously treated with the betamimetic drug fenoterol. The results were compared with those of untreated controls. More deviations from the control were found if the interval between termination of treatment and delivery was shorter than 48 hours. A longer drug-free interval seems more favourable for the metabolic balance of the newborns. Newborns whose mother has received beta-sympathomimetic tocolytic treatment need careful supervision.
D000469:Alkaline Phosphatase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D001786:Blood Glucose / Q000032:analysis; D001798:Blood Proteins / Q000032:analysis; D001806:Blood Urea Nitrogen; D002784:Cholesterol / Q000097:blood; D004983:Ethanolamines / Q000494:pharmacology*; D005260:Female; D005280:Fenoterol / Q000494:pharmacology* / Q000627:therapeutic use; D005312:Fetal Blood / Q000032:analysis*; D005333:Fetus / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D007231:Infant, Newborn; D008431:Maternal-Fetal Exchange; D007752:Obstetric Labor, Premature / Q000517:prevention & control*; D011247:Pregnancy; D012709:Serum Albumin / Q000032:analysis; D014280:Triglycerides / Q000097:blood
D001786:Blood Glucose; D001798:Blood Proteins; D004983:Ethanolamines; D012709:Serum Albumin; D014280:Triglycerides; D005280:Fenoterol; D002784:Cholesterol; D001219:Aspartate Aminotransferases; D000469:Alkaline Phosphatase; D001663:Bilirubin